LKFT
Lakefront Biotherapeutics NV
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
No implied move.
Lakefront Biotherapeutics NV
Expected move
No implied move.
Lakefront Biotherapeutics NV
31.94
−0.34 · −1.05%
Largest filed tie
97.00%
of LKFT revenue · Gilead Sciences
76 managers report $973.8M of Lakefront Biotherapeutics on form 13F for the quarter ended Jun 30 '26. 5 of them hold 80% of it; Gilead Sciences is largest at 51.36%.
No implied move.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Gilead SciencesGilead Sciences | $500.2M | 51.36% | 0.00% | |
| 2 | Tang Capital ManagementTang | $113.5M | 11.66% | 0.00% | |
| 3 | Madison Avenue PartnersMadison Avenue Partners | $103.4M | 10.61% | +39.86% | |
| 4 | Prosight ManagementProsight | $61.3M | 6.29% | +31.83% | |
| 5 | EcoR1 CapitalEcoR1 Capital | $50.0M | 5.13% | 0.00% | |
| 6 | Ameriprise FinancialAmeriprise Financial | $38.1M | 3.92% | −10.70% | |
| 7 | Susquehanna International GroupSusquehanna International | $18.0M | 1.85% | +29.89% | |
| 8 | DME Capital ManagementDME | $14.5M | 1.49% | 0.00% | |
| 9 | Renaissance TechnologiesRenaissance Technologies | $12.2M | 1.26% | +29.30% | |
| 10 | BlackRockBlackRockindex-like | $10.1M | 1.04% | +8.35% | |
| 11 | Point72 Asset ManagementPoint72 | $8.1M | 0.83% | −18.76% | |
| 12 | D. E. ShawD. E. Shaw | $5.9M | 0.61% | −8.29% | |
| 13 | Millennium ManagementMillennium | $5.4M | 0.56% | +67.81% | |
| 14 | UBS GroupUBS | $5.0M | 0.52% | −4.07% | |
| 15 | DAFNA Capital ManagementDAFNA | $3.9M | 0.40% | 0.00% | |
| 16 | Citadel AdvisorsCitadel | $2.6M | 0.27% | −39.83% | |
| 17 | Two Sigma InvestmentsTwo Sigma | $2.5M | 0.25% | +216.12% | |
| 18 | Norges BankNorges Bankindex-like | $2.3M | 0.24% | — | |
| 19 | Alps AdvisorsAlps | $2.0M | 0.20% | +22.11% | |
| 20 | Goldman Sachs GroupGoldman Sachs | $1.7M | 0.17% | +24.71% | |
| 21 | American Century CompaniesAmerican Century Companies | $1.2M | 0.13% | +5.19% | |
| 22 | Barometer Capital ManagementBarometer | $1.2M | 0.13% | +7.09% | |
| 23 | Morgan StanleyMorgan Stanley | $1.1M | 0.12% | +41.56% | |
| 24 | Schonfeld Strategic AdvisorsSchonfeld Strategic | $977,256 | 0.10% | new | |
| 25 | Marshall WaceMarshall Wace | $971,321 | 0.10% | new |
No implied move.
No thesis.